1. Home
  2. IMCR vs QCRH Comparison

IMCR vs QCRH Comparison

Compare IMCR & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.59

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

QCRH

QCR Holdings Inc.

HOLD

Current Price

$95.29

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCR
QCRH
Founded
2008
1993
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
IMCR
QCRH
Price
$28.59
$95.29
Analyst Decision
Buy
Buy
Analyst Count
10
4
Target Price
$66.33
$98.25
AVG Volume (30 Days)
432.7K
84.2K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
0.44%
EPS Growth
30.39
11.62
EPS
0.25
1.99
Revenue
$249,428,000.00
$165,999,610.00
Revenue This Year
$14.57
$8.46
Revenue Next Year
$8.21
$5.59
P/E Ratio
$114.16
$47.34
Revenue Growth
43.05
20.72
52 Week Low
$27.56
$64.23
52 Week High
$40.71
$97.25

Technical Indicators

Market Signals
Indicator
IMCR
QCRH
Relative Strength Index (RSI) 49.22 59.02
Support Level $27.66 $86.16
Resistance Level $31.56 N/A
Average True Range (ATR) 1.21 2.27
MACD 0.04 0.12
Stochastic Oscillator 51.86 76.04

Price Performance

Historical Comparison
IMCR
QCRH

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.

Share on Social Networks: